ClinicalTrials.gg
RecruitingNCT07030192Updated Nov 3, 2026

Peer Support Workers Study

An interventional study of Emergency Department Peer Availability in Substance Use Disorder (SUD), sponsored by University of British Columbia. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by University of British Columbia · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Nov 2024, registered Jun 2025).
  • Started Nov 2024; still recruiting 1 year 11 months later.
Updated Nov 3, 2026Primary completion movedStudy completion moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
3,781
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 81 studies in Substance-Related Disorders with a site in Canada — 26 open to participants now, 29 under way, none of them phase 3. Substance-Related Disorders · Canada.

Planned enrollment
4th of 71
3,781 · median 74
Started
2024
with 4 others
No phase
52 of 81
16 open now
Primary completion
2028-03
later than 23 of 28 live
Registered
76th of 81
by date
Lead sponsor
6 of 81
University of British Columbia

Among the 81 studies in Substance-Related Disorders with a site in Canada, this one is the 4th largest by planned enrollment of the 71 interventional ones that give a count, is one of 5 that started in 2024, is one of 52 with no phase, reaches primary completion later than 23 of the 28 other live ones, and was the 76th registered.

Substance-Related Disorders

2,242 studies on the registry are indexed under Substance-Related Disorders; 408 are open to participants now.

Browse Substance-Related Disorders studies →

Open to participants now

26 of the 81 studies in Substance-Related Disorders with a site in Canada are open now. Recruiting first, the newest first:

20 more — sign in →

All 26 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 266 Substance-Related Disorders studies recruiting now, 130 (49%) set no upper age limit and 117 (44%) stop at 75 or younger; 55 take children under 18; 90 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 81 studies in Substance-Related Disorders with a site in Canada, or all of them as a file.
02

Study summary

Many people with high-risk opioid use visit emergency departments (EDs), facing a high risk of death if they leave before completing care. Peer support workers (Peers) - people with lived experience of substance use - may improve patient comfort, reduce early departures, and potentially lower mortality rates. This study aims to evaluate how a hospital-implemented ED Peer program can enhance patient support, reduce barriers to care, and provide harm-reduction resources in a person-centred and trauma-informed manner. The study will assess whether Peer availability and direct Peer-patient interactions are associated with improved ED care outcomes, including reduced leaving before treatment completion, as well as subsequent healthcare utilization, overdose, mortality, and other relevant patient outcomes.

Read the detailed description

The study was initially designed as a feasibility evaluation of the ED Peer program and of the use of a randomized shift schedule to assign Peer availability. As program implementation progressed and staffing stabilized, the evaluation framework was refined to examine both the effect of Peer availability and outcomes associated with direct Peer-patient interaction.

From 23 November 2024 through 16 October 2025, Peer availability was assigned according to an a priori randomized shift schedule developed in collaboration with human resources and ED operational leadership. Following achievement of full Peer staffing, the program transitioned to routine clinical operation.

The study has two main analytic objectives: 1) during the shift-randomization period, investigators will compare outcomes between shifts with and without scheduled Peer availability among patients presenting with substance use-related concerns; 2) investigators will evaluate outcomes associated with direct Peer-patient interaction by comparing patients who interacted with a Peer with comparable patients who did not interact with a Peer.

The primary outcome is leaving before treatment completion (LBTC). Additional outcomes will include measures of ED care, subsequent healthcare utilization, substance use treatment, overdose, mortality, and other relevant clinical and health-service outcomes.

Investigators will request routinely collected records for Vancouver General Hospital ED visits during the study period. Records of eligible ED patients presenting during the study period will be linked to provincial administrative data to evaluate outcomes. Data sources will include the National Ambulatory Care Reporting System (NACRS), Discharge Abstract Database (DAD), Vital Statistics, PharmaNet, Medical Services Plan (MSP), and the Central Demographics File. Population Data BC and Health Data Platform BC will support secure data linkage, and additional relevant datasets may be explored where useful to the study objectives.

These data will support cohort definition, construction of comparison groups, development of propensity scores, sensitivity analyses, and evaluation of outcomes including receipt of ED treatments and referrals, ED revisits, hospitalizations, overdose, opioid agonist therapies and other addiction treatments, mortality, and other relevant health-service outcomes.

Investigators will also obtain records of security-related events occurring during ED visits over the study period. These data will be used to examine whether Peer availability is associated with differences in events such as need for de-escalation or other security involvement.

03

Conditions studied

  • Substance Use Disorder (SUD)

Keywords

  • Peer support workers
  • Substance use
  • Emergency department
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Emergency Department (ED) patient at Vancouver General Hospital (VGH)
  • Age 18 years or older
  • Identified as using substances
  • Able to receive or decline peer support services during the ED visit

Exclusion criteria

Exclusion Criteria:

  • Under 18 years of age
  • Does not report substance use
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
3,781 participants (estimated)

Study arms

  • Experimental
    Peer Support Intervention

    Investigators will evaluate the Peer Support intervention using two analytical approaches: 1. Primary Analysis (Intention-to-Treat): Peer Available Shift Patients who presented to the emergency department (ED) with substance use-related complaints during shifts when a Peer support worker was scheduled to be available, according to an a priori randomized schedule. Patients may or may not have directly interacted with a Peer during their ED visit. All eligible patients will be analyzed according to their randomized shift assignment, regardless of whether a direct Peer-patient interaction occurred. 2. Secondary Analysis: Interacted With Peer Patients who presented to the ED with substance use-related concerns and directly interacted with a Peer support worker during their ED visit. Peer activities may have included harm reduction support, provision of naloxone and sterile drug use supplies, linkage to substance use treatment, and connections to follow-up care and community resources.

    Behavioral: Emergency Department Peer Availability

  • No intervention
    No Peer Support Intervention

    Investigators will define the comparison group using two approaches: 1. Primary Analysis (Intention-to-Treat): No Peer Available Shift Patients presenting to the ED with substance use-related complaints during shifts randomized to no Peer availability. 2. Secondary Analysis: Did Not Interact With Peer Patients presenting with similar substance use-related complaints who did not directly interact with a Peer. Investigators will use propensity score weighting to improve comparability with patients who received Peer support. The model will include relevant covariates (e.g., age, sex, area-level deprivation, prior substance use-related ED visits and hospitalizations, and prescriptions for substance dependence medications recorded in PharmaNet during the previous 12 months).

Interventions

  • BehavioralEmergency Department Peer Availability

    During intervention shifts, Peer support workers were scheduled to be available in the emergency department to provide support to patients with substance use-related concerns. Peer support workers offered services tailored to individual patients' needs, including referrals to clinical and social support services (e.g., social work, addictions specialists, Indigenous patient navigators, and community-based addiction services), provision of resources (e.g., blankets, food, naloxone kits, sterile drug use supplies, and information brochures), emotional support, and communication support between patients and healthcare providers regarding patients' conditions and ED care. The primary analysis will evaluate the effect of randomized Peer availability using an intention-to-treat approach. The secondary analysis will evaluate outcomes associated with actual Peer-patient interactions by comparing patients who received Peer support with comparable patients who did not.

06

What researchers measure

Primary outcomes

  1. Leaving Before Treatment Completion (LBTC)

    Investigators will measure LBTC among ED patients with substance use-related complaints (e.g., substance withdrawal, misuse/intoxication, overdose, and localized swelling/redness). Investigators will evaluate LBTC using two approaches: 1. Primary Analysis (Intention-to-Treat): Peer vs. No Peer Shifts Investigators will classify eligible ED visits based on the randomized Peer schedule. For each shift, investigators will calculate the percentage of eligible visits resulting in LBTC. Linear regression will be used to compare LBTC percentages between Peer and No Peer shifts, regardless of actual Peer interaction. 2. Secondary Analysis: Peer Interaction vs. No Peer Interaction Investigators will use propensity score weighting to improve comparability between patients who interacted with a Peer and those who did not. Mixed-effects logistic regression will be used to compare LBTC probabilities between groups, accounting for clustering by shift and adjusting for relevant covariates.

    Time frame: From enrollment through 12 months of follow-up

Secondary outcomes

  1. Distribution of randomized Peer shifts by day of week (feasibility outcome)

    Assessed by examining the distribution of scheduled Peer shifts across each day of the week over the 48-week randomized schedule period. The schedule was developed in collaboration with human resources and ED operational leadership and approved as meeting hospital employee policy. The randomization approach used block-based scheduling with built-in constraints (e.g., mandatory weekends off). This outcome evaluates whether the resulting schedule achieved a balanced weekday/weekend distribution. Unit of Measure: Number and percentage of Peer shifts scheduled per day of the week

    Time frame: From study initiation to achievement of full Peer staffing, approximately one year

  2. ED-based substance use and harm reduction interventions

    Secondary outcomes will include receipt of naloxone kits, opioid agonist therapy doses, and withdrawal treatments during the ED visit. Investigators will compare counts of these outcomes between intervention (Peer) and control (no Peer) groups using multivariable count regression. Investigators will assess clustering of outcomes by shift and adjust for the same covariates included in the primary analysis.

    Time frame: Baseline

  3. 30-day health care utilization and clinical events (e.g., drug poisoning, mortality)

    Exploratory outcomes will include ED visits, hospitalizations, drug poisoning, and mortality within 30 days following the index ED visit. Investigators will analyze counts of these events using multivariable count regression, with the log-transformed length of follow-up included as an offset term where applicable, and will conduct time-to-event analyses using Cox regression. Investigators will assess clustering of outcomes by shift and adjust for the same covariates included in the primary analysis.

    Time frame: From enrollment through 30 days of follow-up from ED visit

  4. Security-related events during ED visits

    Investigators will obtain records of security-related events occurring during ED visits over the study period from the ED security event database. Investigators will assess whether Peer availability was associated with differences in the frequency and type of security-related events, including escalation events and incidents requiring security involvement.

    Time frame: Baseline

  5. Thematic summary of Indigenous patients' experiences with the Peer program

    Indigenous patient perspectives on the Peer program will be collected through surveys, culturally grounded storytelling and sharing circles. Sessions will be guided by open-ended questions to explore perceived safety, support, and emotional impact of Peer involvement in the emergency department. Transcripts will be analyzed using Indigenous-informed thematic analysis to identify key insights and priorities for culturally safe care. Unit of Measure: Themes and narratives identified through qualitative analysis

    Time frame: Within 6 months after the patient's ED visit involving Peer interaction

  6. Thematic summary of healthcare providers' perceptions of the Peer program assessed through focus groups

    Acceptability of the Peer program among healthcare providers will be evaluated using semi-structured focus groups conducted periodically post-implementation. Discussions will explore perceived value, observed patient impact, integration into ED workflows, challenges, and suggestions for improvement. Audio recordings will be transcribed and analyzed using thematic content analysis to identify recurring patterns and representative quotes. Unit of Measure: Thematic categories identified through qualitative analysis

    Time frame: From 12-24 months after Peer program implementation

  7. Thematic summary of PWLLE perceptions and experiences of the Peer program assessed through focus groups

    Perspectives of people with lived and living experience (PWLLE) on the Peer program will be evaluated using semi-structured focus groups. Discussions will explore participants' perceptions of the value and accessibility of Peer support, experiences of substance use-related care in the ED, perceived impacts of the Peer program, barriers and gaps in care, and suggestions for improving Peer support and program delivery. Audio recordings will be transcribed and analyzed using thematic content analysis to identify recurring themes and representative quotes. Unit of Measure: Thematic categories identified through qualitative analysis

    Time frame: From 12-24 months after Peer program implementation

  8. Acceptability of the Peer program evaluated through periodic surveys

    Acceptability and implementation of the Peer program will be assessed through periodic surveys administered to Peers, patients accessing Peer services, members of the ED buprenorphine/naloxone team, and multidisciplinary healthcare providers. Surveys will assess experiences with the Peer program, including perceived value, respect, ease of communication, clarity of information, comfort, confidentiality, teamwork, integration into ED workflows, and perceived facilitators and barriers to implementation.

    Time frame: From 12-24 months after Peer program implementation

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — There is no plan to make individual participant data available to other researchers

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Mar 2028, 40 months after the start.

Of 819 non-industry interventional studies with no phase under Substance-Related Disorders, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 53. This study's planned 40 months is above that.

Counting every sponsor, half of 859 studies reached it within 34 months; a quarter within 17 and three quarters within 53.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: primary completion Sep 2027 → Mar 2028 and completion Dec 2027 → Dec 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2025
First posted
Jun 22, 2025
StartActual
Nov 23, 2024
Primary completionEst.
Mar 2028was Sep 2027
CompletionEst.
Dec 2028was Dec 2027
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Sep 2027→Mar 2028
Nov 3, 2026
Study completion
Dec 2027→Dec 2028
Nov 3, 2026
Enrollment
3181→3781
Nov 3, 2026
Interventions
Added Behavioral: Emergency Department Peer Availability; removed Behavioral: Peer support service. Arm changed Peer support service→Peer Support Intervention; No Peer intervention→No Peer Support Intervention
Nov 3, 2026
Primary outcomes
1 added, 6 removed
What changed in the outcomes
  • AddedLeaving Before Treatment Completion (LBTC)Time frame: From enrollment through 12 months of follow-up
  • RemovedDistribution of randomized Peer shifts by day of weekTime frame: Over the 48-week randomized schedule period approved to meet hospital staffing policy
  • RemovedProportion of Peer interactions with complete standardized documentationTime frame: Up to 15 months post-study initiation
  • RemovedIdentification of substance use-related ED visits for Peer and No Peer shift comparisonTime frame: Up to 15 months post-study initiation
  • RemovedCharacterization of Patients Receiving the Peer InterventionTime frame: Baseline. Up to 15 months post-study initiation.
  • RemovedPatients leaving the ED prior to completing careTime frame: Baseline. Data will be linked and assessed at the conclusion of the feasibility study, up to 15 months post-study initiation.
  • Removed"Treatment effect in the treated" analysisTime frame: Up to 15 months post-study initiation
Nov 3, 2026
Secondary outcomes
1 edited, 1 time frame changed, 6 added, 1 removed, 1 description edited
What changed in the outcomes
  • EditedThematic summary of Indigenous patients' experiences with the Peer program based on storytelling and sharing circlesTime frame: Within 6 months after the patient's ED visit involving Peer interaction
  • AddedDistribution of randomized Peer shifts by day of week (feasibility outcome)Time frame: From study initiation to achievement of full Peer staffing, approximately one year
  • AddedED-based substance use and harm reduction interventionsTime frame: Baseline
  • Added30-day health care utilization and clinical events (e.g., drug poisoning, mortality)Time frame: From enrollment through 30 days of follow-up from ED visit
  • AddedSecurity-related events during ED visitsTime frame: Baseline
  • AddedThematic summary of PWLLE perceptions and experiences of the Peer program assessed through focus groupsTime frame: From 12-24 months after Peer program implementation
  • AddedAcceptability of the Peer program evaluated through periodic surveysTime frame: From 12-24 months after Peer program implementation
  • RemovedPatient-reported acceptability of the Peer program using the Peer patient surveyTime frame: Up to 15 months post-study initiation
  • Time frameThematic summary of healthcare providers' perceptions of the Peer program assessed through focus groupsFrom 3 to 15 months after program implementation → From 12-24 months after Peer program implementation
  • DescriptionThematic summary of healthcare providers' perceptions of the Peer program assessed through focus groups: how it is measured was reworded
Nov 3, 2026
Title
Peer Support Workers Feasibility Study
Nov 3, 2026
Sponsor
Collaborators added: BC Centre for Disease Control·Health Data Platform BC·Population Data BC; collaborators removed: BC Centers for Disease Control
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Primary completion Sep 2027→Mar 2028
    Study completion Dec 2027→Dec 2028
    Enrollment 3181→3781
    Primary outcomes 1 added, 6 removed
    What changed in the outcomes
    • AddedLeaving Before Treatment Completion (LBTC)Time frame: From enrollment through 12 months of follow-up
    • RemovedDistribution of randomized Peer shifts by day of weekTime frame: Over the 48-week randomized schedule period approved to meet hospital staffing policy
    • RemovedProportion of Peer interactions with complete standardized documentationTime frame: Up to 15 months post-study initiation
    • RemovedIdentification of substance use-related ED visits for Peer and No Peer shift comparisonTime frame: Up to 15 months post-study initiation
    • RemovedCharacterization of Patients Receiving the Peer InterventionTime frame: Baseline. Up to 15 months post-study initiation.
    • RemovedPatients leaving the ED prior to completing careTime frame: Baseline. Data will be linked and assessed at the conclusion of the feasibility study, up to 15 months post-study initiation.
    • Removed"Treatment effect in the treated" analysisTime frame: Up to 15 months post-study initiation
    Secondary outcomes 1 edited, 1 time frame changed, 6 added, 1 removed, 1 description edited
    What changed in the outcomes
    • EditedThematic summary of Indigenous patients' experiences with the Peer program based on storytelling and sharing circlesTime frame: Within 6 months after the patient's ED visit involving Peer interaction
    • AddedDistribution of randomized Peer shifts by day of week (feasibility outcome)Time frame: From study initiation to achievement of full Peer staffing, approximately one year
    • AddedED-based substance use and harm reduction interventionsTime frame: Baseline
    • Added30-day health care utilization and clinical events (e.g., drug poisoning, mortality)Time frame: From enrollment through 30 days of follow-up from ED visit
    • AddedSecurity-related events during ED visitsTime frame: Baseline
    • AddedThematic summary of PWLLE perceptions and experiences of the Peer program assessed through focus groupsTime frame: From 12-24 months after Peer program implementation
    • AddedAcceptability of the Peer program evaluated through periodic surveysTime frame: From 12-24 months after Peer program implementation
    • RemovedPatient-reported acceptability of the Peer program using the Peer patient surveyTime frame: Up to 15 months post-study initiation
    • Time frameThematic summary of healthcare providers' perceptions of the Peer program assessed through focus groupsFrom 3 to 15 months after program implementation → From 12-24 months after Peer program implementation
    • DescriptionThematic summary of healthcare providers' perceptions of the Peer program assessed through focus groups: how it is measured was reworded
    Interventions Added Behavioral: Emergency Department Peer Availability; removed Behavioral: Peer support service. Arm changed Peer support service→Peer Support Intervention; No Peer intervention→No Peer Support Intervention
    Sponsor Collaborators added: BC Centre for Disease Control·Health Data Platform BC·Population Data BC; collaborators removed: BC Centers for Disease Control
    Title Peer Support Workers Feasibility Study
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07030192
Collaborators
Vancouver Coastal Health Research Institute, BC Centre for Disease Control, Health Data Platform BC, Population Data BC
Responsible party
Jessica Moe (Associate Professor UBC Department of Emergency Medicine, University of British Columbia) — Principal investigator
First posted
Jun 22, 2025
Start date
Nov 23, 2024
Primary completion
Mar 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Nov 3, 2026

Study contacts

Cindy Liu, BSc
Contact
cindy.q.liu@ubc.ca
778-929-1281
Elle Wang, MSc
Contact
elle.wang@ubc.ca
604-615-2538
Jessica Moe, MD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion